DCZ3301

CAS No. 2136278-38-9

DCZ3301( —— )

Catalog No. M37649 CAS No. 2136278-38-9

DCZ3301 is a novel aryl-guanidino inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 256 Get Quote
10MG 375 Get Quote
25MG 545 Get Quote
50MG 767 Get Quote
100MG 1008 Get Quote
500MG 2034 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DCZ3301
  • Note
    Research use only, not for human use.
  • Brief Description
    DCZ3301 is a novel aryl-guanidino inhibitor.
  • Description
    DCZ3301 is a potent aryl-guanidino inhibitor. DCZ3301 inhibits cell proliferation, induces G2/M cell cycle arrest and apoptosis. DCZ3301 inhibits the activation of the PI3K/AKT pathway by downregulating the protein expression of PI3K and phosphorylation of AKT. DCZ3301 can be used in research of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2136278-38-9
  • Formula Weight
    464.83
  • Molecular Formula
    C20H16ClF3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C=1C=C(C(NC)=O)N=CC1)C=2C=CC(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=N)=NC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xiao W, et, al. DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma. Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):643-650.?
molnova catalog
related products
  • (S)-Ebalzotan

    (S)-Ebalzotan is the S configuration of Ebalzotan.Ebalzotan is a 5-HT1A receptor agonist that is used in the study of depression.

  • Pyrazole

    1H-Pyrazole is a versatile building block with a vast applications in organic synthesis. The derivatives of Pyrazole are used in medicine for their analgesic anti-inflammatory antipyretic antiarrhythmic tranquilizing muscle relaxing psychoanaleptic anticonvulsant monoamineoxidase inhibiting antidiabetic and antibacterial activities.

  • Koumine

    Koumine has antineoplastic effect, may be a future breast cancer chemotherapeutic agent.